Approval · Notice of Compliance 15713 · 2014
CLOLAR: Notice of Compliance 15713
Issued June 11, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15713
- Date
- June 11, 2014
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug product manufacturing site
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLOLAR | Not yet assigned | — |
Medicinal ingredients
- CLOFARABINE 1 MG per ML